Trials / Sponsors / Escape Bio, Inc.
Escape Bio, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene | — | 2022-05-02 |
| Terminated | Parkinson's Disease G2019S LRRK2 Genetic Testing Program Parkinson's Disease | — | 2021-06-08 |